Survivorship Care for People With Cancer in the Indo-Pacific: The Imperative to Harness Political Determinants, International Exchange, and Technological Innovation.
Article in JCO global oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Edward Christopher DeeEdward Christopher Dee, MD, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Frances Dominique V. Ho, BSc, College of Medicine, University of the Philippines, Manila, Philippines; Kaisin Yee, BSc, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA, SingHealth Duke-NUS Global Health Institute, Singapore, Singapore; and Vivian K. Lin, DrPH, MPH, LKS Faculty of Medicine, University of Hong Kong, Hong Kong, China.ORCID 0000-0001-6119-0889
Frances Dominique V HoEdward Christopher Dee, MD, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Frances Dominique V. Ho, BSc, College of Medicine, University of the Philippines, Manila, Philippines; Kaisin Yee, BSc, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA, SingHealth Duke-NUS Global Health Institute, Singapore, Singapore; and Vivian K. Lin, DrPH, MPH, LKS Faculty of Medicine, University of Hong Kong, Hong Kong, China.ORCID 0000-0001-9812-6207
Kaisin YeeEdward Christopher Dee, MD, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Frances Dominique V. Ho, BSc, College of Medicine, University of the Philippines, Manila, Philippines; Kaisin Yee, BSc, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA, SingHealth Duke-NUS Global Health Institute, Singapore, Singapore; and Vivian K. Lin, DrPH, MPH, LKS Faculty of Medicine, University of Hong Kong, Hong Kong, China.ORCID 0000-0001-7830-220X
Vivian K LinEdward Christopher Dee, MD, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Frances Dominique V. Ho, BSc, College of Medicine, University of the Philippines, Manila, Philippines; Kaisin Yee, BSc, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA, SingHealth Duke-NUS Global Health Institute, Singapore, Singapore; and Vivian K. Lin, DrPH, MPH, LKS Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Survivorship Care for People With Cancer in the Indo-Pacific: The Imperative to Harness Political Determinants, International Exchange, and Technological Innovation. · full record | OpenQuestion